Autoimmune hemolytic anemia overview: Difference between revisions
Created page with "__NOTOC__ {{Autoimmune hemolytic anemia}} {{CMG}} '''Assosciate Editor(s)-In-Chief:''' Prashanth Saddala M.B.B.S ==Overview== '''Autoimmune hemol..." |
m Template |
||
| Line 11: | Line 11: | ||
The terminology used in this disease is somewhat ambiguous. Although [[Medical Subject Headings|MeSH]] uses the term "autoimmune hemolytic anemia",<ref>{{MeshName|Autoimmune+hemolytic+anemia}}</ref> some sources prefer the term "immunohemolytic anemia" so drug reactions can be included in this category.<ref name="pmid10387489">{{cite journal |author=Wright MS |title=Drug-induced hemolytic anemias: increasing complications to therapeutic interventions |journal=Clin Lab Sci |volume=12 |issue=2 |pages=115–8 |year=1999 |pmid=10387489 }}</ref><ref name="isbn0-7216-0187-1">{{cite book |author=Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. |title=Robbins and Cotran pathologic basis of disease |publisher=Elsevier Saunders |location=St. Louis, Mo |year=2005 |pages=636 |isbn=0-7216-0187-1 }}</ref>. The [[National Cancer Institute]] considers "immunohemolytic anemia", "autoimmune hemolytic anemia", and "immune complex hemolytic anemia" to all be synonyms.<ref>{{cite web |url=http://www.cancer.gov/templates/db_alpha.aspx?CdrID=523291 |title=Definition of immunohemolytic anemia |work=NCI Dictionary of Cancer Terms |accessdate=2009-02-07| archiveurl= http://web.archive.org/web/20090115195213/http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=523291| archivedate= 15 January 2009 <!--DASHBot-->| deadurl= no}}</ref>. | The terminology used in this disease is somewhat ambiguous. Although [[Medical Subject Headings|MeSH]] uses the term "autoimmune hemolytic anemia",<ref>{{MeshName|Autoimmune+hemolytic+anemia}}</ref> some sources prefer the term "immunohemolytic anemia" so drug reactions can be included in this category.<ref name="pmid10387489">{{cite journal |author=Wright MS |title=Drug-induced hemolytic anemias: increasing complications to therapeutic interventions |journal=Clin Lab Sci |volume=12 |issue=2 |pages=115–8 |year=1999 |pmid=10387489 }}</ref><ref name="isbn0-7216-0187-1">{{cite book |author=Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. |title=Robbins and Cotran pathologic basis of disease |publisher=Elsevier Saunders |location=St. Louis, Mo |year=2005 |pages=636 |isbn=0-7216-0187-1 }}</ref>. The [[National Cancer Institute]] considers "immunohemolytic anemia", "autoimmune hemolytic anemia", and "immune complex hemolytic anemia" to all be synonyms.<ref>{{cite web |url=http://www.cancer.gov/templates/db_alpha.aspx?CdrID=523291 |title=Definition of immunohemolytic anemia |work=NCI Dictionary of Cancer Terms |accessdate=2009-02-07| archiveurl= http://web.archive.org/web/20090115195213/http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=523291| archivedate= 15 January 2009 <!--DASHBot-->| deadurl= no}}</ref>. | ||
==Overview== | |||
==Historical Perspective== | |||
==Classification== | |||
==Pathophysiology== | |||
==Causes== | |||
==Differentiating [Disease] from Other Diseases== | |||
==Epidemiology and Demographics== | |||
==Risk Factors== | |||
==Screening== | |||
==Natural History, Complications, and Prognosis== | |||
===Natural History=== | |||
===Complications=== | |||
===Prognosis=== | |||
==Diagnosis== | |||
===Diagnostic Criteria=== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory Findings=== | |||
===Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | |||
===Medical Therapy=== | |||
===Surgery=== | |||
===Prevention=== | |||
==References== | ==References== | ||
| Line 17: | Line 63: | ||
{{Hematology}} | {{Hematology}} | ||
[[Category:Hematology]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 16:08, 20 June 2016
|
Autoimmune hemolytic anemia Microchapters |
|
Differentiating Autoimmune hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune hemolytic anemia overview On the Web |
|
American Roentgen Ray Society Images of Autoimmune hemolytic anemia overview |
|
Directions to Hospitals Treating Autoimmune hemolytic anemia |
|
Risk calculators and risk factors for Autoimmune hemolytic anemia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S
Overview
Autoimmune hemolytic anemia (AIHA) is a type of hemolytic anemia where the body's immune system attacks its own red blood cells (RBCs), leading to their destruction (hemolysis). Antibodies and associated complement system components become fixed onto the RBC surface. These antibodies can be detected with the direct antiglobulin test, also known as the direct Coombs test. AIHA can also be induced by several drugs including methyl-dopa and fluarabine.
Autoimmunity must not be confused with alloimmunity.
The terminology used in this disease is somewhat ambiguous. Although MeSH uses the term "autoimmune hemolytic anemia",[1] some sources prefer the term "immunohemolytic anemia" so drug reactions can be included in this category.[2][3]. The National Cancer Institute considers "immunohemolytic anemia", "autoimmune hemolytic anemia", and "immune complex hemolytic anemia" to all be synonyms.[4].
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating [Disease] from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Natural History
Complications
Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
References
- ↑ Autoimmune+hemolytic+anemia at the US National Library of Medicine Medical Subject Headings (MeSH)
- ↑ Wright MS (1999). "Drug-induced hemolytic anemias: increasing complications to therapeutic interventions". Clin Lab Sci. 12 (2): 115–8. PMID 10387489.
- ↑ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease. St. Louis, Mo: Elsevier Saunders. p. 636. ISBN 0-7216-0187-1.
- ↑ "Definition of immunohemolytic anemia". NCI Dictionary of Cancer Terms. Archived from the original on 15 January 2009. Retrieved 2009-02-07.